Comprehensive overview of biomarkers to predict response to immune checkpoint therapy in lung cancer

Comprehensive overview of biomarkers to predict response to immune checkpoint therapy in lung cancer

Immune checkpoint (IC) therapy has brought a huge revolution in the field of lung cancer treatment over the past decade. It has also revolutionised treatment paradigm and has tremendously improved patient prognosis. IC inhibitors (ICIs) targeting Programmed Cell Death Protein 1/Programmed cell death...

Full description

Bibliographic Details
Main Authors: Kriti Jain, Deepa Mehra, Nirmal Kumar Ganguly, Rashmi Rana, Surajit Ganguly, Shyam Aggarwal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Current Medicine Research and Practice
Subjects:
biomarkers
immune checkpoint inhibitors
immunotherapy
lung cancer
pd-1/pd-l1 antibodies
Online Access:http://www.cmrpjournal.org/article.asp?issn=2352-0817;year=2023;volume=13;issue=5;spage=232;epage=242;aulast=Jain

Internet

http://www.cmrpjournal.org/article.asp?issn=2352-0817;year=2023;volume=13;issue=5;spage=232;epage=242;aulast=Jain

Similar Items